GMJ Technologies, Inc.
Everett, WA
- UEI
- FLYLUW8AM585
- CAGE
- 8HYU4
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 4820 148th Pl SE, Everett, WA 98208, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
Similar vendors
About the company
GMJ Technologies, Inc. is a minority-owned, small disadvantaged business registered in SAM.gov that focuses on developing advanced analytical technologies for the biopharmaceutical and biomedical research sectors. As a for-profit organization, the company specializes in creating innovative analytical tools and instrumentation that support protein characterization, quality control, and research workflows. The company has demonstrated expertise in developing cutting-edge technologies that address critical challenges in biologics research and pharmaceutical development, with a particular emphasis on advanced separation and detection methodologies.
The company has secured multiple federal grant awards from prestigious agencies like the National Institute of General Medical Sciences (NIGMS) and the National Science Foundation (NSF), primarily through Small Business Innovation Research (SBIR) programs. Their recent federal grants have focused on developing sophisticated analytical technologies, including a high-resolution native capillary zone electrophoresis system with inline UV and native mass spectrometry capabilities for characterizing charge variants in biologics, and a microfluidic sodium dodecyl sulfate (SDS) depletion electrophoresis interface for improved characterization of monoclonal antibody fragments. These projects aim to enhance analytical workflows in the biopharmaceutical industry by improving efficiency, precision, and sensitivity in protein therapeutic research and development. The grants, ranging from approximately $350,000 to $358,862, support the company's innovative approach to developing advanced analytical tools that can significantly impact biomedical research and pharmaceutical manufacturing processes.
Quick answers
Is GMJ Technologies, Inc. registered in SAM.gov?
Yes. GMJ Technologies, Inc.'s SAM.gov registration is active through April 3, 2027.
What is GMJ Technologies, Inc.'s most recent federal award?
GMJ Technologies, Inc.'s most recent federal grant award is High-resolution native capillary zone electrophoresis with inline UV and native mass spectrometry for characterizing… (R44GM156142), from National Institute of General Medical Sciences (NIH), on August 1, 2024.
On GovTribe
See GMJ Technologies, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors